Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
AZN and PRR's Arthron Pty Ltd. subsidiary extended to June 30, 2006, their 2004 deal to study Arthron's Fc receptor technology. PRR said the Fc gamma receptor IIa (CD32) is a target for autoimmune di...